Market revenue in 2022 | USD 95.6 million |
Market revenue in 2030 | USD 135.2 million |
Growth rate | 4.4% (CAGR from 2022 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Analyzers |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Analyzers, Reagents & Consumables |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.48% in 2022. Horizon Databook has segmented the Mexico thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The rising prevalence of thrombotic & bleeding disorders and chronic conditions, such as CVDs & ischemic diseases, in the country, is a key factor contributing to market growth. Biomarkers are used to monitor and diagnose these conditions.
The growing awareness and adoption of biomarkers for testing are also contributing to market growth. In addition, rising geriatric population in the country is expected to boost the thrombosis and hemostasis biomarkers market.
For instance, in 2020, the population aged 60 and above reached 14.5 million, accounting for 11% of the total population, according to data from the UN. Some of the key players operating in the country’s thrombosis and hemostasis biomarker market are Thermo Fisher Scientific, Inc., Siemens Healthineers, Abbott, and F. Hoffmann-La Roche AG.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Mexico thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account